Studying headaches in people with MOGAD
Part of Brain & nervous system, Immune system & allergy, Pain clinical trials.
This study looks at headaches in people with MOGAD (a condition where the immune system attacks the nervous system). By understanding how common headaches are and what they feel like, doctors hope to better recognize and treat them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with MOGAD (a rare autoimmune disease that can affect the brain, spinal cord, and optic nerves).
- You are able to understand and sign a consent form to join a research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific gene change in people with MS, NMOSD, or MOGAD to see how common it is. By joining, you help researchers learn more about these conditions and possible future treatments.
This study builds a China-based group of people with neuroinflammatory and demyelination diseases and collects health and MRI (brain scan) information. It may help doctors better understand these conditions over time and improve future treatments.
This study looks at the early signs that happen before a migraine starts, such as fatigue or mood changes. It aims to help people understand their migraine patterns better.
This study looks at blood samples from people with migraine to find proteins and other markers that might explain why migraines happen. The goal is to better understand migraine, which could help find better treatments in the future.
This study looks at what migraine is like for people, such as how often it happens and what might affect it. You will fill out questionnaires, and no drugs or treatments will be tested.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
Hear when a new MOGAD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.